ARCHIVES

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: AACR Voted On Naming Delegates To Congress, Not On Attending; ACCC Membership Over 300

February 17, 1978

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985